Zelboraf / vemurafenib
Specification: 56 tabs per box
ZELBORA is a kinase inhibitor suitable for the treatment of patients with unreexcised or metastatic melanoma with fda-approved testing for BRAFV600E mutations.
We provide customers with quality products and services.
If you would like to leave us a comment please go to contact us